Today’s Solutions: May 23, 2022

Throughout the past decade, it seems like science is getting closer to the reality of gene therapy. Here at The Optimist Daily, we’ve reported on a number of potential uses for the practice, including; curing blindness, reducing obesity, ending malaria, allowing cross species organ transplants, and editing a healthier microbiome, to name a few.

What is age-related macular degeneration AMD?

The latest research points to the possibility of using this therapy to treat age-related macular degeneration (AMD). According to the National Eye Institute, AMD is the leading cause of blindness among older adults in the United States, impacting around two million people. The disease develops when abnormal blood vessels form behind the retina, eventually leading to these vessels leaking blood or plasma causing an infection.

People with this disease have to regularly visit the doctors, every four to eight weeks, to receive injections of aflibercept into the infected eye. Just one missed appointment can result in decreased vision, eventually leading to full blindness.

How does the gene-therapy work?

The experimental gene-therapy acts to fix AMD by adding the genetic information in the eye related cells to self produce aflibercept. Hopefully, people with this disease would just need one preliminary infection and from there on after their own supply could be sustained.

“With this new in-office intravitreal gene therapy, there is potential for a ‘one-and-done’ approach that can not only completely alleviate that treatment burden, but perhaps result in improved visual outcomes,” said Dr. Szilárd Kiss, lead investigator of the study. This treatment could hugely improve the quality of life for sufferers of AMD, also making it easier to stick to treatment outcomes.

How are the clinical trials looking?

As reported by the American Academy of Ophthalmology, the treatment is in phase I clinical trials and results are looking promising. All patients who have received the gene therapy have gone without the need for injection with the maintained vision for at least six months. A win for science and eyes everywhere!

Next, the team needs to enroll a higher number of people in the trails to ensure safety and efficacy. The hope is that within three to five years, this therapy can be commonly accessible to treat AMD.

Source study: American Academy of Ophthalmology (AAO)In-Office Gene Therapy for Wet Age-related Macular Degeneration is Coming

Solutions News Source Print this article
More of Today's Solutions

New program seeks to break the cycle between jail and homelessness

Several factors can lead to homelessness: a lack of affordable housing, high costs of living, and even, sadly, mental illness. Another factor that contributes to homelessness, which is often overlooked, is incarceration.  Many individuals serve ... Read More

How a century-old cargo schooner is bringing back emissions-free shipping

The shipping industry is responsible for 2.5 percent of global greenhouse gas emissions — putting about 940 million tonnes of CO2 into the atmosphere every year. Before 1960, however, when containerization started to take off, ... Read More

Dam! Europe removes record number of river barriers in 2021

In 2021, Spain began a movement to remove dams from the country’s rivers to restore fish migration routes and boost biodiversity across the nation. They successfully took down 108 barriers and inspired other European countries ... Read More

This contact lens releases glaucoma medication

While it is treatable, glaucoma remains a serious eye disease that can damage the optic nerve and lead to blindness if left untreated. Open-angle glaucoma is the most common form of the disease, and research ... Read More

US soccer and national teams reach agreement to close gender pay gap

In a historic win for women’s rights, US Soccer and both the women’s and men’s national teams have proclaimed a collective bargaining agreement to close the gender pay gap and ensure that each player, regardless ... Read More

New immunotherapy drug combo slows liver cancer growth in mice

There is something of an art to the science of medicine. We’ve all heard that everyone’s different, and so is their biology. Sometimes, developing the right treatment for a patient’s condition takes dedicated and creative ... Read More